Gastric intestinal metaplasia without dysplasia, involving the body (corpus) digital illustration

Gastric intestinal metaplasia without dysplasia, involving the body (corpus) Save


ICD-10 code: K31.A12

Disease category: None

Gastric Intestinal Metaplasia without Dysplasia, Involving the Body (Corpus)

Gastric intestinal metaplasia without dysplasia is a condition characterized by the transformation of normal stomach cells into cells resembling those found in the intestines. When this condition affects the body (corpus) of the stomach, it is referred to as gastric intestinal metaplasia involving the corpus.

The corpus of the stomach is responsible for producing gastric acid, enzymes, and mucus required for digestion. When gastric intestinal metaplasia occurs in this region, the normal stomach lining is replaced by cells that resemble those found in the intestines, which can impact the digestive process.

While the exact cause of gastric intestinal metaplasia without dysplasia is not fully understood, it is often associated with long-term inflammation and infection with Helicobacter pylori (H. pylori) bacteria. Other factors, such as smoking, alcohol consumption, a diet high in salt and low in fruits and vegetables, and genetic predisposition, may also contribute to the development of this condition.

Patients with gastric intestinal metaplasia involving the corpus are usually asymptomatic, meaning they do not experience any noticeable symptoms. As a result, the condition is often discovered incidentally during endoscopic examinations performed for other reasons. It is important to note that gastric intestinal metaplasia without dysplasia itself does not typically progress to gastric cancer. However, it is considered a risk factor for the development of gastric cancer in the long term.

Diagnosis of gastric intestinal metaplasia without dysplasia involves taking biopsies during an endoscopy. The pathologist will examine the tissue samples under a microscope to confirm the presence of metaplastic changes. Regular surveillance endoscopies may be recommended to monitor the progression of the condition and detect any potential dysplasia or cancer at an early stage.

  1. Long-term inflammation and H. pylori infection are associated with gastric intestinal metaplasia.
  2. Smoking, alcohol consumption, diet, and genetics may contribute to its development.
  3. Gastric intestinal metaplasia involving the corpus is often asymptomatic.
  4. It is a risk factor for gastric cancer but does not directly progress to cancer.
  5. Diagnosis involves biopsies during endoscopy, followed by regular surveillance.

If you suspect you may have gastric intestinal metaplasia, it is essential to consult with a gastroenterologist who can evaluate your condition and provide appropriate guidance. Remember, early detection and management are crucial to maintaining your digestive health.

Treatment of Gastric intestinal metaplasia without dysplasia, involving the body (corpus):

Treatment Options for Gastric Intestinal Metaplasia without Dysplasia, Involving the Body (Corpus)

Gastric intestinal metaplasia without dysplasia, involving the body (corpus), is a condition characterized by the replacement of the normal gastric lining with intestinal-type cells. Although this condition may not be cancerous, it is considered a risk factor for developing gastric ca...

To see full information about treatment please Sign up or Log in